Infective Endocarditis
Conditions
Brief summary
As recommended in the Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (IE) patients with IE should be evaluated and managed by a multispecialty team including an cardiologist, infectious disease specialist, and cardiac surgeon. Our registry is a prospective, national registry of patients with IE. From January 2013 data from endocarditis board were prospectively recorded using standard definitions during the hospitalization. Patient demographics, clinical, laboratory, and imaging data at the time of IE diagnosis, as well as treatment outcomes were entered into the ER-UHC database.
Detailed description
The primary endpoint will be the 1 year all-cause mortality after treatment begins of IE. We will use 1 year all-cause mortality as the primary endpoint because it has been demonstrated that a period of at least 6 months is necessary to offset the early postoperative mortality related to valve surgery. We also looked at all-cause in-hospital mortality as a secondary endpoint.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients with patients with definitive infective endocarditis
Exclusion criteria
* childs
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All-cause mortality | 1 year | 1-year all-cause mortality |
Secondary
| Measure | Time frame |
|---|---|
| Inhospital all-cause mortality | 1 month |
Countries
Germany